Adalimumab/infliximab/methotrexate: Visceral leishmaniasis: 2 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1260, 2009-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab/infliximab/methotrexate: Sarcoidosis: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Adalimumab/methotrexate: Visceral leishmaniasis in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1357, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Leflunomide/methotrexate: Visceral leishmaniasis (first report with leflunomide), medullary hypoplasia and haemophagocytic syndrome: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1422, 2012-01 ,pp. : 30-30

Adis International

Access to resources Recommend Favorite

Adalimumab/infliximab: Cutaneous sarcoidosis: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1308, 2010-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Adalimumab/infliximab: Autoimmune neutropenia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1416, 2012-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite